What is Amparo Gordian's NPI number?

Amparo Gordian's National Provider Identifier (NPI) is 1205039997, a unique 10-digit ID issued by CMS for use in standard healthcare transactions.

What is Amparo Gordian's specialty?

Amparo Gordian is listed in the NPPES registry with a primary specialty of Rheumatology Physician (Allopathic & Osteopathic Physicians).

Where is Amparo Gordian located?

Amparo Gordian's practice location on file with NPPES is 4900 Manatee Ave W Ste 201, Bradenton, FL 34209-3859.

What is Amparo Gordian's phone number?

The practice phone number listed in the NPPES registry for Amparo Gordian is (941) 746-5200.

Does Amparo Gordian accept Medicare?

Amparo Gordian is approved to bill Medicare according to CMS PECOS enrollment data (2026.04.01). Confirm current participation with the provider before scheduling.

Is Amparo Gordian's NPI active?

Yes — Amparo Gordian's NPI (1205039997) is active in the NPPES registry as of the last update on 2025-08-22.

IndividualActiveAccepts Medicare

Amparo Gordian, MD

NPI 1205039997 · Rheumatology Physician · Bradenton, FL

Amparo Gordian, MD is a Rheumatology Physician provider in Bradenton, FL (NPI 1205039997).

Provider details

NPI number: 1205039997
Entity type: Individual
Primary specialty: Rheumatology PhysicianAllopathic & Osteopathic Physicians
Credential: MD
Sex: Female
Sole proprietor: No
License: 149438 (FL)

Practice location

4900 Manatee Ave W Ste 201

Bradenton, FL 34209-3859

Phone: (941) 746-5200

Street-level locationGet directions

More FL providers

Mailing address

4900 Manatee Ave W Ste 201

Bradenton, FL 34209-3859

Specialties & taxonomies

Rheumatology PhysicianPrimary207RR0500XLicense 149438 (FL)
Allopathic & Osteopathic Physicians

Enrolled with Medicare as Practitioner - Rheumatology · source: CMS PECOS Public Provider Enrollment (2026.04.01)

Profile Score

Detailed profile(93/100 index)

A profile completeness & documented-activity index — NOT a quality, outcomes, or patient-satisfaction rating.

Registry tenure25% of score
19 yrs in NPPES registry
Profile completeness25% of score
100% of core fields populated
Practice footprint15% of score
1 documented practice location
Medicare service volume (vs. specialty peers)25% of score
4,719 Medicare services, 2024 (ranked within specialty)
Open Payments transparency10% of score
Has Open Payments disclosures (2024)

Medicare volume is ranked against active providers in the same specialty. Signals a provider has no public data for (e.g. Medicare claims) are left out of the score entirely — never counted as zero — so providers without that data are not penalized. See the full formula and weights in our methodology.

What this provider does (Medicare)

Based on Medicare fee-for-service claims, 2024; not all care is captured.

Service (HCPCS)	Medicare services	Typical Medicare-allowed (2024)
Administration of Chemotherapy Into Vein, 1 Hour Or Less96413	872	$122
Established Patient Office Or Other Outpatient Visit With Moderate Level of Decision Making, If Using Time, 30 Minutes Or More99214	840	$125
Administration of Non-Hormonal Anti-Neoplastic Chemotherapy Under Skin Or Into Muscle96401	750	$68
Measurement of Antibody for Assessment of Autoimmune Disorder, Any Method86235	444	$18
Infusion Into a Vein for Therapy, Prevention, Or Diagnosis, 1 Hour Or Less96365	342	$59
Insertion of Needle Into Vein for Collection of Blood Sample36415	324

What this provider prescribes (Medicare Part D)

Top drugs by Medicare Part D claim volume, 2024 · 19 distinct drugs on file.

Drug	Part D claims (2024)	Beneficiaries
Prednisone	341	100
Methotrexate Sodiumbrand: Methotrexate	275	82
Hydroxychloroquine Sulfate	272	89
Duloxetine Hcl	88	24
Leflunomide	85	32
Gabapentin	80	22
Alendronate Sodium	60	17

Transparency — industry payments

Based on CMS Open Payments, 2024; not all care is captured.

$2,917 across 142 records (Open Payments 2024)

Open Payments discloses payments and transfers of value (meals, travel, consulting, research, royalties) from drug and device makers to providers. This is a transparency signal, not a verdict — such payments are legal and common, and their presence is neither an endorsement nor a criticism. Source: CMS Open Payments, program year 2024.

Enumerated: 2007-06-08
Last updated: 2025-08-22
Certified: 2025-08-22

Frequently asked questions

What is Amparo Gordian's NPI number?: Amparo Gordian's National Provider Identifier (NPI) is 1205039997, a unique 10-digit ID issued by CMS for use in standard healthcare transactions.
What is Amparo Gordian's specialty?: Amparo Gordian is listed in the NPPES registry with a primary specialty of Rheumatology Physician (Allopathic & Osteopathic Physicians).
Where is Amparo Gordian located?: Amparo Gordian's practice location on file with NPPES is 4900 Manatee Ave W Ste 201, Bradenton, FL 34209-3859.
What is Amparo Gordian's phone number?: The practice phone number listed in the NPPES registry for Amparo Gordian is (941) 746-5200.
Does Amparo Gordian accept Medicare?: Amparo Gordian is approved to bill Medicare according to CMS PECOS enrollment data (2026.04.01). Confirm current participation with the provider before scheduling.
Is Amparo Gordian's NPI active?: Yes — Amparo Gordian's NPI (1205039997) is active in the NPPES registry as of the last update on 2025-08-22.

Source: CMS NPPES Data Dissemination (June 2026). NPI Central is not affiliated with CMS. Data is provided as-is from the public registry.

What this provider does (Medicare)

Based on Medicare fee-for-service claims, 2024; not all care is captured.

Service (HCPCS)	Medicare services	Typical Medicare-allowed (2024)
Administration of Chemotherapy Into Vein, 1 Hour Or Less96413	872	$122
Established Patient Office Or Other Outpatient Visit With Moderate Level of Decision Making, If Using Time, 30 Minutes Or More99214	840	$125
Administration of Non-Hormonal Anti-Neoplastic Chemotherapy Under Skin Or Into Muscle96401	750	$68
Measurement of Antibody for Assessment of Autoimmune Disorder, Any Method86235	444	$18
Infusion Into a Vein for Therapy, Prevention, Or Diagnosis, 1 Hour Or Less96365	342	$59
Insertion of Needle Into Vein for Collection of Blood Sample36415	324

Drug

Part D claims (2024)

Beneficiaries

Prednisone

341

100

Methotrexate Sodiumbrand: Methotrexate

275

Hydroxychloroquine Sulfate

272

Duloxetine Hcl

Leflunomide

Gabapentin

Alendronate Sodium

Transparency — industry payments

Based on CMS Open Payments, 2024; not all care is captured.

$2,917 across 142 records (Open Payments 2024)

Provider details

Practice location

Mailing address

Specialties & taxonomies

Profile Score

What this provider does (Medicare)

What this provider prescribes (Medicare Part D)

Transparency — industry payments

Registry dates

Frequently asked questions

Specialties & taxonomies

Frequently asked questions

Profile Score

What this provider does (Medicare)

What this provider prescribes (Medicare Part D)

Transparency — industry payments